Maura Murphy, Ph.D. Director, Product Development
Maura Murphy joined Recro as director of product development in 2019. Supporting Recro’s expanded development capabilities, Maura oversees the formulation and analytical development of client products through commercial tech transfer. With 20 years of pharmaceutical expertise, she specializes in the product development of immediate release (IR) and modified release (MR) oral solid dosage forms. She has extensive experience in bioavailability-enhancing drug delivery platforms such as amorphous solid dispersions and nanoparticles.
Prior to joining Recro, Maura held leadership positions in product development at iCeutica, Pharmaceutics International, Inc. (Pii), and Vertex Pharmaceuticals. Maura’s career highlights include the development of the early phase oral formulation targeting the Hepatitis C virus utilizing amorphous solid dispersion technology, and optimizing an oral formulation utilizing nanoparticles to reduce the dose by half and remove the food effect (compared to the RLD).
Maura earned her Ph.D. in pharmaceutical sciences from the University of Maryland, Baltimore and a bachelor’s of science in pharmacy from the University of Texas at Austin. She holds three patents related to pharmaceutical compositions.